Assessment of clinico-epidemiological profile of Hepatocellular carcinoma in the last two decades
Abstract Background Hepatocellular carcinoma represents 85%—90% of primary liver tumors; it represents the 2nd leading cause of cancer-related death all over the world. There is a growing incidence of HCC worldwide and similarly, the incidence of HCC has almost doubled over the last decade in Egypt....
Main Authors: | Ahmed Abdel Kareem Ali, Salah El Gamal, Rokiah Anwar, Eman Elzahaf, Dina Eskandere |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2023-03-01
|
Series: | The Egyptian Journal of Internal Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s43162-023-00201-8 |
Similar Items
-
Editor’s Pick: Hepatocellular Carcinoma. Part 1: Epidemiology, Risk Factors, Pathogenesis, and Pathology
by: Lior Charach,, et al.
Published: (2017-06-01) -
Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular Carcinoma
by: Koen G. A. M. Hussaarts, et al.
Published: (2021-01-01) -
Diffuse infiltrative hepatocellular carcinoma or cirrhosis?
by: Jarosław Koza, et al.
Published: (2017-12-01) -
Diffuse infiltrative hepatocellular carcinoma or cirrhosis?
by: Jarosław Koza, et al.
Published: (2017-12-01) -
Stereotactic body radiation therapy (SBRT) in patients with hepatocellular carcinoma and oligometastatic liver disease
by: Sabine Gerum, et al.
Published: (2018-05-01)